Verrica Pharmaceuticals

VRCANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$87.268 M

$5.08 -5.22%

Close of 7 Aug 2026

Revenue

$35.6M

#2845 by revenue

Earnings

-$17.9M

Loss-making

Shares outstanding

17,178,786

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#312Zhengye BiotechnologyZYBT$89.6M
#313Fortress BiotechFBIO$88.7M
#314Verrica PharmaceuticalsVRCA$87.3M
#315Gossamer BioGOSS$87.0M
#316MAIA BiotechnologyMAIA$86.3M

Where these numbers come from

Share counts and financials for Verrica Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.